US 12,138,490 B2
Methods for treating hair loss disorders
Angela M. Christiano, Mahwah, NJ (US); and Raphael Clynes, West Nyack, NY (US)
Assigned to THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, New York, NY (US)
Filed by THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, New York, NY (US)
Filed on Apr. 6, 2022, as Appl. No. 17/714,964.
Application 17/714,964 is a continuation of application No. 16/299,382, filed on Mar. 12, 2019, granted, now 11,298,570.
Application 16/299,382 is a continuation of application No. 15/668,814, filed on Aug. 4, 2017, granted, now 10,265,258.
Application 15/668,814 is a continuation of application No. 14/821,623, filed on Aug. 7, 2015, granted, now 9,895,301, issued on Feb. 20, 2018.
Application 14/821,623 is a continuation of application No. 13/886,252, filed on May 2, 2013, granted, now 9,198,911, issued on Dec. 1, 2015.
Application 13/886,252 is a continuation in part of application No. PCT/US2013/034688, filed on Mar. 29, 2013.
Application 13/886,252 is a continuation in part of application No. PCT/US2011/059029, filed on Nov. 2, 2011.
Claims priority of provisional application 61/645,499, filed on May 10, 2012.
Claims priority of provisional application 61/617,225, filed on Mar. 29, 2012.
Claims priority of provisional application 61/409,509, filed on Nov. 2, 2010.
Prior Publication US 2023/0111697 A1, Apr. 13, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61Q 7/00 (2006.01); A61K 8/41 (2006.01); A61K 8/49 (2006.01); A61K 8/64 (2006.01); A61K 31/137 (2006.01); A61K 31/277 (2006.01); A61K 31/407 (2006.01); A61K 31/437 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/529 (2006.01); A61K 31/5377 (2006.01); A61K 31/553 (2006.01); A61K 31/63 (2006.01); A61K 31/7052 (2006.01); A61K 31/713 (2006.01)
CPC A61Q 7/00 (2013.01) [A61K 8/41 (2013.01); A61K 8/4953 (2013.01); A61K 8/64 (2013.01); A61K 31/137 (2013.01); A61K 31/277 (2013.01); A61K 31/407 (2013.01); A61K 31/437 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/529 (2013.01); A61K 31/5377 (2013.01); A61K 31/553 (2013.01); A61K 31/63 (2013.01); A61K 31/7052 (2013.01); A61K 31/713 (2013.01); A61K 2800/782 (2013.01)] 16 Claims
 
1. A method of treating alopecia areata in a human subject in need thereof, the method consisting of orally administering to the human subject an effective amount of a small molecule JAK3 inhibitor, wherein the alopecia areata in the human subject is treated.